In summary, before administering PD-1 inhibitor therapy, we constructed and verified a nomogram for predicting PFS in NPC patients based on indicators related to liver function, and found that it improved the accuracy of prediction. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.